Cargando…
Non-Pharmacological Therapeutic Options for Liver Metastases in Advanced Neuroendocrine Tumors
The incidence of liver metastasis in digestive neuroendocrine tumors is high. Their presence appears as an important prognostic factor in terms of quality of life and survival. These tumors may be symptomatic because of the tumor burden itself and/or the hormonal hyper-secretion induced by the tumor...
Autores principales: | Dermine, Solène, Palmieri, Lola-Jade, Lavolé, Julie, Barré, Amélie, Dohan, Antony, Abou Ali, Einas, Cottereau, Anne-Ségolène, Gaujoux, Sébastien, Brezault, Catherine, Chaussade, Stanislas, Coriat, Romain |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6912565/ https://www.ncbi.nlm.nih.gov/pubmed/31703375 http://dx.doi.org/10.3390/jcm8111907 |
Ejemplares similares
-
Medical Treatment of Advanced Pancreatic Neuroendocrine Neoplasms
por: Palmieri, Lola-Jade, et al.
Publicado: (2020) -
Indications of Peptide Receptor Radionuclide Therapy (PRRT) in Gastroenteropancreatic and Pulmonary Neuroendocrine Tumors: An Updated Review
por: Camus, Baptiste, et al.
Publicado: (2021) -
Systemic therapy in metastatic pancreatic adenocarcinoma: current practice and perspectives
por: Lellouche, Lisa, et al.
Publicado: (2021) -
The Role of Interventional Radiology for the Treatment of Hepatic Metastases from Neuroendocrine Tumor: An Updated Review
por: Barat, Maxime, et al.
Publicado: (2020) -
Organ Preservation after Endoscopic Resection of Early Esophageal Cancer with a High Risk of Lymph Node Involvement
por: Dermine, Solène, et al.
Publicado: (2020)